Y-Intercept (HK)’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$368K	Buy	+405,043	New	+$368K	0.01%	1301
2023 Q2	–	Sell	-66,298	Closed	-$99.4K	–	1525
2023 Q1	$99.4K	Buy	+66,298	New	+$99.4K	0.01%	1056
2022 Q3	–	Sell	-44,829	Closed	-$71K	–	1135
2022 Q2	$71K	Buy	+44,829	New	+$71K	0.01%	736